NCT03678883 2024-11-07
9-ING-41 in Patients with Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
Clinical Trials
11 trialsNCT01775475 2022-10-10
Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma
AIDS Malignancy Consortium
Phase 2 Completed
NCT05518383 2022-08-26
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4 Recruiting
NCT00074191 2017-04-21
Protocol-A
OHSU Knight Cancer Institute
Phase 2 Completed
NCT01989052 2016-08-04
Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma
Duke University
Phase 1 Terminated
NCT00317408 2015-09-25
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)
Phase NA Unknown
NCT00003929 2012-03-20
Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Case Comprehensive Cancer Center
Phase 2 Withdrawn
NCT00003113 2011-01-17
Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT00003114 2010-06-11
Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00049439 2010-06-11
Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00989352 2009-10-05
PRIMAIN
University Hospital Freiburg
Phase 2 Unknown